Driven by the frequently increased expression level of SGK1 in pathologies, particularly in cancer and T cell‐mediated disorders, we sought to identify post‐translational processes and interacting proteins that modulate the abundance of SGK1 in cells and in mouse tissues. The gene discussed is SGK1; the disease is cancer.